Rockefeller Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-10
| Closed | – | – | 3209 |
|
2022
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 4091 |
|
2022
Q3 | $0 | Buy |
+10
| New | – | ﹤0.01% | 4214 |
|
2021
Q3 | – | Sell |
-27
| Closed | -$6K | – | 3803 |
|
2021
Q2 | $6K | Hold |
27
| – | – | ﹤0.01% | 2980 |
|
2021
Q1 | $8K | Hold |
27
| – | – | ﹤0.01% | 2695 |
|
2020
Q4 | $6K | Sell |
27
-15
| -36% | -$3.33K | ﹤0.01% | 2382 |
|
2020
Q3 | $10K | Buy |
42
+6
| +17% | +$1.43K | ﹤0.01% | 2017 |
|
2020
Q2 | $13K | Sell |
36
-8
| -18% | -$2.89K | ﹤0.01% | 1817 |
|
2020
Q1 | $12K | Buy |
44
+16
| +57% | +$4.36K | ﹤0.01% | 1688 |
|
2019
Q4 | $9K | Buy |
28
+1
| +4% | +$321 | ﹤0.01% | 1639 |
|
2019
Q3 | $7K | Buy |
+27
| New | +$7K | ﹤0.01% | 1533 |
|
2019
Q2 | – | Sell |
-15
| Closed | -$8K | – | 1863 |
|
2019
Q1 | $8K | Buy |
+15
| New | +$8K | ﹤0.01% | 1536 |
|